|
Quotes & Info
|
| CXM > SEC Filings for CXM > Form 8-K on 21-Oct-2008 | All Recent SEC Filings |
21-Oct-2008
Other Events, Financial Statements and Exhibits
On October 20, 2008, Cardium Therapeutics, Inc. ("Cardium") issued a press release announcing Cardium and its operating unit, InnerCool Therapies, Inc., have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the RapidBlue™ System, an endovascular temperature modulation device. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
(d) Exhibits.
99.1 Press Release of Cardium issued on October 20, 2008.
|
|